Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) has issued an update.
Hansoh Pharmaceutical Group has announced a final ordinary cash dividend of HKD 0.20 per share for the financial year ended 31 December 2025. The update mainly confirms the date for shareholders’ approval, which is set for 26 June 2026, aligning the payout timetable for investors.
Subject to approval, the shares will trade ex-dividend on 3 July 2026, with the record date fixed as 9 July 2026 and payment scheduled for 24 July 2026. The clarified schedule provides income visibility for shareholders and signals the company’s intent to return cash to investors following its 2025 performance.
The most recent analyst rating on (HK:3692) stock is a Buy with a HK$47.00 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a Hong Kong-listed pharmaceutical company. It focuses on developing and marketing prescription drugs, with its shares traded under stock code 03692 on the Hong Kong Stock Exchange, serving healthcare markets in China and beyond.
Average Trading Volume: 9,534,243
Technical Sentiment Signal: Buy
Current Market Cap: HK$238.7B
See more insights into 3692 stock on TipRanks’ Stock Analysis page.